Scichilone Nicola, Marchese Roberto, Soresi Simona, Interrante Amelia, Togias Alkis, Bellia Vincenzo
Istituto di Medicina Generale e Pneumologia, Cattedra di Malattie dell'Apparato Respiratorio, Università di Palermo, 90146 Palermo, Italy.
Respir Med. 2007 May;101(5):951-6. doi: 10.1016/j.rmed.2006.09.009. Epub 2006 Oct 17.
We have previously reported that the magnitude of deep inspiration (DI)-induced bronchodilation is only slightly reduced in mild asthmatics, compared to healthy subjects. The aim of this study was to evaluate whether increased severity of asthma is associated with impairment in the ability of DI to induce changes in lung volume. Thirty-six consecutive asthmatics recruited from the Pulmonary and the Allergy Outpatient Clinics of the Institute of Respiratory Diseases of the University of Palermo were divided into 3 groups: Intermittent (I), Mild Persistent (MP) and Moderate-Severe (MS), based on GINA guidelines. Single dose methacholine (Mch) bronchoprovocations were performed in the absence of DI, to induce at least 15% reduction in inspiratory vital capacity (IVC) from baseline. The post-Mch IVC was followed by 4 consecutive DI and by another IVC, to determine the bronchodilatory effect of DI. The bronchodilatory effect of DI was found to significantly decrease with increasing severity of asthma (I: 68+/-5.4%, MP: 45+/-7.2%, MS: 4+/-15.6%; ANOVA: P<0.0001). Bronchodilation by DI, but not FEV(1) or FEV(1)/FVC, was also inversely correlated to symptom scores (r=-0.42, P=0.01) and to weekly salbutamol usage (r=-0.47, P=0.004). These observations provide support to the hypothesis that the attenuation of the bronchodilatory effect of DI contributes to the severity of the clinical manifestations of asthma.
我们之前曾报道,与健康受试者相比,轻度哮喘患者深吸气(DI)诱导的支气管扩张幅度仅略有降低。本研究的目的是评估哮喘严重程度增加是否与DI诱导肺容积变化的能力受损有关。从巴勒莫大学呼吸疾病研究所的肺病和过敏门诊连续招募了36名哮喘患者,根据全球哮喘防治创议(GINA)指南将其分为3组:间歇期(I)、轻度持续期(MP)和中度至重度(MS)。在没有DI的情况下进行单剂量乙酰甲胆碱(Mch)支气管激发试验,以使吸气肺活量(IVC)从基线至少降低15%。Mch激发试验后的IVC之后是连续4次DI和另一次IVC,以确定DI的支气管扩张作用。发现DI的支气管扩张作用随着哮喘严重程度的增加而显著降低(I组:68±5.4%,MP组:45±7.2%,MS组:4±15.6%;方差分析:P<0.0001)。DI引起的支气管扩张,但不是FEV(1)或FEV(1)/FVC,也与症状评分呈负相关(r=-0.42,P=0.01)和与每周沙丁胺醇使用量呈负相关(r=-0.47,P=0.004)。这些观察结果支持了这样的假设,即DI支气管扩张作用的减弱导致了哮喘临床表现的严重程度。